Janus Henderson Group PLC Trinity Biotech PLC Transaction History

Janus Henderson Group PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 18, 2020	SELL	$0.69 - $1.2 $504,158 - $876,798	-730,665 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$1.21 - $2.59 $581,419 - $1.24 Million	-480,512 Reduced 39.67%	730,665 $884,000
Q1 2019 Apr 30, 2019	SELL	$2.31 - $3.22 $411,332 - $573,372	-178,066 Reduced 12.82%	1,211,177 $3.45 Million
Q4 2018 Feb 06, 2019	SELL	$2.14 - $4.26 $15,795 - $31,443	-7,381 Reduced 0.53%	1,389,243 $3.18 Million
Q3 2018 Nov 09, 2018	SELL	$3.76 - $5.08 $26,286 - $35,514	-6,991 Reduced 0.5%	1,396,624 $5.59 Million
Q2 2018 Aug 10, 2018	SELL	$4.46 - $5.2 $10,142 - $11,824	-2,274 Reduced 0.16%	1,403,615 $7.02 Million
Q1 2018 May 14, 2018	SELL	$5.08 - $6.06 $42,682 - $50,916	-8,402 Reduced 0.59%	1,405,889 $7.24 Million
Q2 2017 Aug 17, 2017	BUY	N/A	1,414,291	1,414,291 $8.49 Million

30.2K

Ticker TRIB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 38,107,600
Market Cap $46.5M
Description
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious dis...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.